Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

v3.23.1
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Cash flows from operating activities:    
Net income (loss) $ 12,772 $ (21,746)
Adjustments to reconcile net income (loss) to net cash flows from operating activities:    
Depreciation and amortization 47,877 57,225
Stock-based compensation expense 8,612 8,931
Deferred tax provision (benefit) 268 (16)
Asset write-downs 0 10,486
Defined benefit plan settlement losses 1,271 30,856
Defined benefit plan settlement payments (24,242) (35,706)
Proceeds from the settlement of cash flow hedges 10,474 0
Changes in working capital items (10,885) 18,842
Decrease in other assets 3,298 5,823
Decrease in other liabilities (2,083) (6,265)
Other operating activities, net (2,651) 4,293
Net cash provided by operating activities 44,711 72,723
Cash flows from investing activities:    
Capital expenditures (23,772) (28,096)
Acquisitions, net of cash acquired (7,586) 0
Proceeds from sale of investments 0 3,127
Other investing activities, net 155 230
Net cash used in investing activities (31,203) (24,739)
Cash flows from financing activities:    
Proceeds from long-term debt 414,843 342,847
Payments on long-term debt (441,963) (353,385)
Purchases of treasury stock (2,739) (12,138)
Dividends (14,126) (13,952)
Acquisition holdback and contingent consideration payments 0 (613)
Other financing activities (914) (1,434)
Net cash used in financing activities (44,899) (38,675)
Effect of exchange rate changes on cash 1,893 (1,580)
Net change in cash, cash equivalents and restricted cash (29,498) 7,729
Cash, cash equivalents and restricted cash at beginning of year 71,414 68,343
Cash, cash equivalents and restricted cash at end of period $ 41,916 $ 76,072